Identification of a novel truncating PALB2mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women

被引:0
作者
William D Foulkes
Parviz Ghadirian
Mohammed Reza Akbari
Nancy Hamel
Sylvie Giroux
Nelly Sabbaghian
Andrew Darnel
Robert Royer
Aletta Poll
Eve Fafard
André Robidoux
Ginette Martin
Tarek A Bismar
Marc Tischkowitz
Francois Rousseau
Steven A Narod
机构
[1] McGill University,Program in Cancer Genetics, Departments of Oncology and Human Genetics
[2] Sir M. B. Davis-Jewish General Hospital,Segal Cancer Centre
[3] McGill University Health Centre,The Research Institute
[4] Centre de recherche du CHUQ/HSFA,The CanGèneTest Research Consortium on Genetic Laboratory Services
[5] Centre Hospitalier Université de Montréal (Hôtel-Dieu campus),Epidemiology Research Unit, Research Centre
[6] University of Toronto,Women's College Research Institute
[7] Centre Hospitalier Université de Laval,Centre de recherche du CHUQ – Hôpital St
[8] Centre Hospitalier Université de Montréal (Hôtel-Dieu campus),François d'Assise
[9] McGill University,Department of Surgery
来源
Breast Cancer Research | / 9卷
关键词
Breast Cancer; Fanconi Anemia; Founder Mutation; Familial Breast Cancer; Hereditary Breast Cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 145 条
[1]  
Ford D(1998)Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families Am J Hum Genet 3 676-689
[2]  
Easton DF(1997)Population genetics of BRCA1 and BRCA2 Am J Hum Genet 5 1013-1020
[3]  
Stratton M(2004)BRCA1 and BRCA2: 1994 and beyond Nat Rev Cancer 9 665-676
[4]  
Narod S(1998)Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families Am J Hum Genet 5 1341-1351
[5]  
Goldgar D(2004)Significant proportion of breast and/or ovarian cancer families of French Canadian descent harbor 1 of 5 BRCA1 and BRCA2 mutations Int J Cancer 3 411-419
[6]  
Devilee P(2007)Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer J Med Genet 2 107-121
[7]  
Bishop DT(2004)Tracing the network connecting BRCA and Fanconi anaemia proteins Nat Rev Cancer 4 266-276
[8]  
Weber B(2006)Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2 Mol Cell 6 719-729
[9]  
Lenoir G(2007)Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer Nat Genet 2 162-164
[10]  
Changclaude J(2007)PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene Nat Genet 2 165-167